609342-52-1

Upstream product

• 64415-07-2 4-mercapto 7-trifluoromethyl quinoline 
• 609342-43-0 Acetic acid (1S,2R,3R,4S,6R)-2-acetoxy-4,6-diazido-3-chloromethoxy-cyclohexyl ester 
• 609342-42-9 Acetic acid (1R,2S,3R,5S,6R)-2-acetoxy-3,5-diazido-6-methylsulfanylmethoxy-cyclohexyl ester 
• 236115-61-0 [(1S,2S,3R,4S,6R)-2-acetoxy-4,6-diazido-3-hydroxy-cyclohexyl] acetate 

Downstream Products

• 870180-47-5 [(1R,2S,3R,5S,6R)-3,5-Diazido-2-hydroxy-6-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-acetic acid 
• 870180-79-3 2-[(1R,2S,3R,5S,6R)-3,5-Diazido-2-hydroxy-6-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-N-(3-dimethylamino-propyl)-acetamide 
• 870180-77-1 2-[(1S,2R,3R,4S,6R)-4,6-Diazido-2-hydroxy-3-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-N-(3-dimethylamino-propyl)-acetamide 
• 870180-67-9 (3-{2-[(1S,2R,3R,4S,6R)-4,6-Diamino-2-hydroxy-3-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-ethylamino}-propyl)-carbamic acid tert-butyl ester 
• 870180-71-5 (3-{2-[(1R,2S,3R,5S,6R)-3,5-Diamino-2-hydroxy-6-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-ethylamino}-propyl)-carbamic acid tert-butyl ester 
• 870180-59-9 (3-{2-[(1S,2R,3R,4S,6R)-4,6-Diazido-2-hydroxy-3-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-ethylamino}-propyl)-carbamic acid tert-butyl ester 
• 870180-63-5 (3-{2-[(1R,2S,3R,5S,6R)-3,5-Diazido-2-hydroxy-6-(7-trifluoromethyl-quinolin-4-ylsulfanylmethoxy)-cyclohexyloxy]-ethylamino}-propyl)-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

The synthesis and 16S A-site rRNA recognition of carbohydrate-free aminoglycosides

The first carbohydrate-free aminoglycoside analogs bearing the 2-deoxystreptamine moiety were synthesized from asymmetrically protected 2-deoxystrepamine and subsequently demonstrated to have significant binding to the 16S A-site rRNA target and moderate

Antimicrobial 2-deoxystreptamine compounds

The present invention is directed to analogs of aminoglycoside compounds of the class having a glycosylated 2-deoxystreptamine (2-DOS) ring as well as their preparation and use as prophylactic or therapeutics against microbial infection. Compounds of the

Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay

A good starting point for the design of potent bactericidal compounds is the aminoglycoside paromomycin (1). The A-ring (shown in red) was replaced with a range of heterocycles. An ESIMS-based RNA-binding assay was used to screen the binding affinities of